Table 4. ITPase activities stratified by genotype, compared between control and HIV+-population.
| Control | HIV+ | |||
| ITPA genotype | ITPase activity ± SD | % activity** | HIV+ ITPase activity ± SD | % activity** |
| Wild type | 5.38±1.52 | 100 | 4.31±1.39* | 80.1 |
| c.94 C>A heterozygote | 1.43±0.55 | 26.6 | 0.86±0.23* | 16.0 |
| c.124+21 A>C heterozygote | 2.61±0.66 | 48.5 | 2.67±0.69 | 49.6 |
| c.94C>A homozygote | 0.00±0.05 | 0.03 | ||
| c.124+21 C>C homozygote | 1.81±0.19 | 33.6 | 1.99±0.73 | 37.0 |
ITPase activity in mol IMP/(mol Hb × h).
*p<0.001.
**% activity wild type: residual ITPase activity relative to wild type ITPase activity.